1. Home
  2. NNNN vs HTT Comparison

NNNN vs HTT Comparison

Compare NNNN & HTT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Anbio Biotechnology Class A Ordinary Shares

NNNN

Anbio Biotechnology Class A Ordinary Shares

HOLD

Current Price

$6.81

Market Cap

340.2M

Sector

Health Care

ML Signal

HOLD

Logo High Templar Tech Limited American depositary shares each representing one Class A ordinary share

HTT

High Templar Tech Limited American depositary shares each representing one Class A ordinary share

HOLD

Current Price

$2.50

Market Cap

392.9M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
NNNN
HTT
Founded
2021
2014
Country
Germany
China
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
340.2M
392.9M
IPO Year
2023
2017

Fundamental Metrics

Financial Performance
Metric
NNNN
HTT
Price
$6.81
$2.50
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
92.5K
93.2K
Earning Date
04-07-2026
05-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$446.57
$4.14
Revenue Growth
N/A
N/A
52 Week Low
$7.08
$1.88
52 Week High
$51.33
$3.91

Technical Indicators

Market Signals
Indicator
NNNN
HTT
Relative Strength Index (RSI) 26.92 51.00
Support Level N/A $2.34
Resistance Level $12.62 $2.59
Average True Range (ATR) 1.62 0.06
MACD -0.12 0.01
Stochastic Oscillator 3.06 66.67

Price Performance

Historical Comparison
NNNN
HTT

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).

About HTT High Templar Tech Limited American depositary shares each representing one Class A ordinary share

High Templar Tech Ltd is an enabler of financial technology. High Templar is focusing on exploring business opportunities globally to satisfy clients' demand by leveraging its technology know-how and financial service capabilities. The company focus empowering financial institutions with its technological capabilities, helping them improve marketing and operational efficiency and efficiently connect their diverse financial products with online traffic.

Share on Social Networks: